Hellstrom A, Smith LE, Dammann O (2013) Retinopathy of prematurity. Lancet 382(9902):1445–1457. https://doi.org/10.1016/S0140-6736(13)60178-6

PubMed  PubMed Central  Google Scholar 

Fu Z, Nilsson AK, Hellstrom A, Smith LEH (2022) Retinopathy of prematurity: metabolic risk factors. Elife 11. https://doi.org/10.7554/eLife.80550

Sato T, Wada K, Arahori H, Kuno N, Imoto K, Iwahashi-Shima C, Kusaka S (2012) Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity. Am J Ophthalmol 153(2):327–333e321. https://doi.org/10.1016/j.ajo.2011.07.005

PubMed  Google Scholar 

Zehden JA, Mortensen XM, Reddy A, Zhang AY (2022) Systemic and ocular adverse events with Intravitreal Anti-VEGF therapy used in the treatment of Diabetic Retinopathy: a review. Curr Diab Rep 22(10):525–536. https://doi.org/10.1007/s11892-022-01491-y

PubMed  Google Scholar 

Yossuck P, Yan Y, Tadesse M, Higgins RD (2000) Dexamethasone and critical effect of timing on retinopathy. Invest Ophthalmol Vis Sci 41(10):3095–3099

PubMed  Google Scholar 

Nakao S, Hata Y, Miura M, Noda K, Kimura YN, Kawahara S, Kita T, Hisatomi T, Nakazawa T, Jin Y, Dana MR, Kuwano M, Ono M, Ishibashi T, Hafezi-Moghadam A (2007) Dexamethasone inhibits interleukin-1beta-induced corneal neovascularization: role of nuclear factor-kappab-activated stromal cells in inflammatory angiogenesis. Am J Pathol 171(3):1058–1065. https://doi.org/10.2353/ajpath.2007.070172

PubMed  PubMed Central  Google Scholar 

Cebeci Z, Kir N (2015) Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant. Diabetes Metab Syndr Obes 8:555–566. https://doi.org/10.2147/DMSO.S73540

PubMed  PubMed Central  Google Scholar 

Rotschild T, Nandgaonkar BN, Yu K, Higgins RD (1999) Dexamethasone reduces oxygen induced retinopathy in a mouse model. Pediatr Res 46(1):94–100. https://doi.org/10.1203/00006450-199907000-00016

PubMed  Google Scholar 

Lawas-Alejo PA, Slivka S, Hernandez H, Bry K, Hallman M (1999) Hyperoxia and glucocorticoid modify retinal vessel growth and interleukin-1 receptor antagonist in newborn rabbits. Pediatr Res 45(3):313–317. https://doi.org/10.1203/00006450-199903000-00004

PubMed  Google Scholar 

Wenzel A, Grimm C, Seeliger MW, Jaissle G, Hafezi F, Kretschmer R, Zrenner E, Reme CE (2001) Prevention of photoreceptor apoptosis by activation of the glucocorticoid receptor. Invest Ophthalmol Vis Sci 42(7):1653–1659

PubMed  Google Scholar 

Fu J, Lam TT, Tso MO (1992) Dexamethasone ameliorates retinal photic injury in albino rats. Exp Eye Res 54(4):583–594. https://doi.org/10.1016/0014-4835(92)90137-h

PubMed  Google Scholar 

She H, Nakazawa T, Matsubara A, Connolly E, Hisatomi T, Noda K, Kim I, Gragoudas ES, Miller JW (2008) Photoreceptor protection after photodynamic therapy using dexamethasone in a rat model of choroidal neovascularization. Invest Ophthalmol Vis Sci 49(11):5008–5014. https://doi.org/10.1167/iovs.07-1154

PubMed  Google Scholar 

Gallina D, Zelinka CP, Cebulla CM, Fischer AJ (2015) Activation of glucocorticoid receptors in Muller glia is protective to retinal neurons and suppresses microglial reactivity. Exp Neurol 273:114–125. https://doi.org/10.1016/j.expneurol.2015.08.007

PubMed  PubMed Central  Google Scholar 

Hao W, Wenzel A, Obin MS, Chen CK, Brill E, Krasnoperova NV, Eversole-Cire P, Kleyner Y, Taylor A, Simon MI, Grimm C, Reme CE, Lem J (2002) Evidence for two apoptotic pathways in light-induced retinal degeneration. Nat Genet 32(2):254–260. https://doi.org/10.1038/ng984

PubMed  Google Scholar 

Hou Y, Xie J, Wang S, Li D, Wang L, Wang H, Ni X, Leng S, Li G, Hou M, Peng J (2022) Glucocorticoid receptor modulates myeloid-derived suppressor cell function via mitochondrial metabolism in immune thrombocytopenia. Cell Mol Immunol 19(7):764–776. https://doi.org/10.1038/s41423-022-00859-0

PubMed  PubMed Central  Google Scholar 

Chiang MF, Quinn GE, Fielder AR, Ostmo SR, Paul Chan RV, Berrocal A, Binenbaum G, Blair M, Peter Campbell J, Capone A Jr., Chen Y, Dai S, Ells A, Fleck BW, Good WV, Elizabeth Hartnett M, Holmstrom G, Kusaka S, Kychenthal A, Lepore D, Lorenz B, Martinez-Castellanos MA, Ozdek S, Ademola-Popoola D, Reynolds JD, Shah PK, Shapiro M, Stahl A, Toth C, Vinekar A, Visser L, Wallace DK, Wu WC, Zhao P, Zin A (2021) International classification of retinopathy of Prematurity, Third Edition. Ophthalmology 128(10):e51–e68. https://doi.org/10.1016/j.ophtha.2021.05.031

PubMed  Google Scholar 

Ohnell HM, Andreasson S, Granse L (2022) Dexamethasone Eye drops for the treatment of retinopathy of Prematurity. Ophthalmol Retina 6(2):181–182. https://doi.org/10.1016/j.oret.2021.09.002

PubMed  Google Scholar 

Smith LE, Wesolowski E, McLellan A, Kostyk SK, D’Amato R, Sullivan R, D’Amore PA (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35(1):101–111

PubMed  Google Scholar 

Connor KM, Krah NM, Dennison RJ, Aderman CM, Chen J, Guerin KI, Sapieha P, Stahl A, Willett KL, Smith LE (2009) Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc 4(11):1565–1573. https://doi.org/10.1038/nprot.2009.187

PubMed  PubMed Central  Google Scholar 

International Committee for the Classification of Retinopathy of P (2005) The International classification of retinopathy of Prematurity revisited. Arch Ophthalmol 123(7):991–999. https://doi.org/10.1001/archopht.123.7.991

Google Scholar 

Stahl A, Chen J, Sapieha P, Seaward MR, Krah NM, Dennison RJ, Favazza T, Bucher F, Lofqvist C, Ong H, Hellstrom A, Chemtob S, Akula JD, Smith LE (2010) Postnatal weight gain modifies severity and functional outcome of oxygen-induced proliferative retinopathy. Am J Pathol 177(6):2715–2723. https://doi.org/10.2353/ajpath.2010.100526

PubMed  PubMed Central  Google Scholar 

Kramer A, Green J, Pollard J Jr., Tugendreich S (2014) Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 30(4):523–530. https://doi.org/10.1093/bioinformatics/btt703

PubMed  Google Scholar 

Binet F, Cagnone G, Crespo-Garcia S, Hata M, Neault M, Dejda A, Wilson AM, Buscarlet M, Mawambo GT, Howard JP, Diaz-Marin R, Parinot C, Guber V, Pilon F, Juneau R, Laflamme R, Sawchyn C, Boulay K, Leclerc S, Abu-Thuraia A, Cote JF, Andelfinger G, Rezende FA, Sennlaub F, Joyal JS, Mallette FA, Sapieha P (2020) Neutrophil extracellular traps target senescent vasculature for tissue remodeling in retinopathy. Science 369(6506). https://doi.org/10.1126/science.aay5356

Pagliarani A, Nesci S, Ventrella V (2013) Modifiers of the oligomycin sensitivity of the mitochondrial F1F0-ATPase. Mitochondrion 13(4):312–319. https://doi.org/10.1016/j.mito.2013.04.005

PubMed  Google Scholar 

Rivera JC, Holm M, Austeng D, Morken TS, Zhou TE, Beaudry-Richard A, Sierra EM, Dammann O, Chemtob S (2017) Retinopathy of prematurity: inflammation, choroidal degeneration, and novel promising therapeutic strategies. J Neuroinflammation 14(1):165. https://doi.org/10.1186/s12974-017-0943-1

PubMed  PubMed Central  Google Scholar 

Karlstetter M, Scholz R, Rutar M, Wong WT, Provis JM, Langmann T (2015) Retinal microglia: just bystander or target for therapy? Prog Retin Eye Res 45:30–57. https://doi.org/10.1016/j.preteyeres.2014.11.004

PubMed  Google Scholar 

Wright K, Wright SP (1994) Lack of association of glucocorticoid therapy and retinopathy of prematurity. Arch Pediatr Adolesc Med 148(8):848–852. https://doi.org/10.1001/archpedi.1994.02170080078015

PubMed  Google Scholar 

Sobel DB, Philip AG (1992) Prolonged dexamethasone therapy reduces the incidence of cryotherapy for retinopathy of prematurity in infants of less than 1 kilogram birth weight with bronchopulmonary dysplasia. Pediatrics 90(4):529–533

PubMed  Google Scholar 

Zeng Y, Ge G, Lei C, Zhang M (2022) Beyond fetal immunity: a systematic review and Meta-analysis of the Association between Antenatal Corticosteroids and Retinopathy of Prematurity. Front Pharmacol 13:759742. https://doi.org/10.3389/fphar.2022.759742

PubMed  PubMed Central  Google Scholar 

Movsas TZ, Spitzer AR, Gewolb IH (2016) Postnatal corticosteroids and risk of retinopathy of prematurity. J AAPOS 20(4):348–352. https://doi.org/10.1016/j.jaapos.2016.05.008

PubMed  Google Scholar 

Du J, McEwen B, Manji HK (2009) Glucocorticoid receptors modulate mitochondrial function: a novel mechanism for neuroprotection. Commun Integr Biol 2(4):350–352. https://doi.org/10.4161/cib.2.4.8554

PubMed  PubMed Central  Google Scholar 

Kokkinopoulou I, Moutsatsou P (2021) Mitochondrial glucocorticoid receptors and their actions. Int J Mol Sci 22(11). https://doi.org/10.3390/ijms22116054

Hunter RG, Seligsohn M, Rubin TG, Griffiths BB, Ozdemir Y, Pfaff DW, Datson NA, McEwen BS (2016) Stress and corticosteroids regulate rat hippocampal mitochondrial DNA gene expression via the glucocorticoid receptor. Proc Natl Acad Sci U S A 113(32):9099–9104. https://doi.org/10.1073/pnas.1602185113

PubMed  PubMed Central  Google Scholar 

Psarra AM, Sekeris CE (2011) Glucocorticoids induce mitochondrial gene transcription in HepG2 cells: role of the mitochondrial glucocorticoid receptor. Biochim Biophys Acta 1813(10):1814–1821. https://doi.org/10.1016/j.bbamcr.2011.05.014

PubMed  Google Scholar 

Chap Z, Jones RH, Chou J, Hartley CJ, Entman ML, Field JB (1986) Effect of dexamethasone on hepatic glucose and insulin metabolism after oral glucose in conscious dogs. J Clin Invest 78(5):1355–1361. https://doi.org/10.1172/JCI112722

PubMed  PubMed Central  Google Scholar 

Koorneef LL, van der Meulen M, Kooijman S, Sanchez-Lopez E, Scheerstra JF, Voorhoeve MC, Ramesh ANN, Rensen PCN, Giera M, Kroon J, Meijer OC (2022) Dexamethasone-associated metabolic effects in male mice are partially caused by depletion of endogenous corticosterone. Front Endocrinol (Lausanne) 13:960279. https://doi.org/10.3389/fendo.2022.960279

PubMed  Google Scholar 

Amin SB, Sinkin RA, McDermott MP, Kendig JW (1999) Lipid intolerance in neonates receiving dexamethasone for bronchopulmonary dysplasia. Arch Pediatr Ad